A 49 year old man who developed idiopathic pulmonary haemorrhage and glomerulonephritis responded initially to immunosuppressive treatment and plasmapheresis. However, he died later from massive pulmonary haemorrhage and necropsy showed cytomegalovirus infection of the lungs. We propose that relapse of pulmonary haemorrhage may be associated with cytomegalovirus infection and that preventive measures against acquiring the virus through blood products should be considered for elective transfusions in view of the relatively good long term prognosis of this syndrome.
Introduction
In 1919, Goodpasture first described the clinical syndrome of intrapulmonary haemorrhage and glomerulonephritis.1 Subsequently, Lerner et al. identified the anti-glomerular basement membrane (anti-GBM) antibody as an important aetiological factor in the pathogenesis of the syndrome. 2 Thomas & Irwin first classified diffuse pulmonary haemorrhage on an immunopathological basis depending on the presence or absence of anti-GBM antibody or immune complexes.3 A recent review of 40 patients with pulmonary haemorrhage and glomerulonephritis (PHG) identified 3 subgroups: anti-GBM disease, systemic vasculitis and idiopathic. streaked sputum. A chest X-ray showed patchy shadowing in the right lung base, and he was referred to hospital. On examination after admission he was febrile but there were no stigmata of infective endocarditis or vasculitis. A mitral stenotic murmur and right basal crackles were detected. His condition deteriorated rapidly with spiking fever, increasing dyspnoea and widespread crackles. A chest X-ray 4 days after the initial one showed extensive bilateral shadowing ( Figure 1 ).
His ESR was 118mm/h, haemoglobin 6.6 g/dl, white cell count 9.7 x 109/l, urea 12.7 mmol/l and creatinine 193jmol/l. Pus cells, red cell casts and protein were detected in his urine. A diagnosis of pulmonary haemorrhage and glomerulonephritis (PHG) was made and he was transfused 2 units of packed red cells. Blood culture, atypical pneumonia and viral titres were negative. Examination revealed no ulceration of his nasopharynx or larynx. Renal biopsy showed crescentic glomerulonephritis with over 60% of glomeruli being involved (Figure 2a ). Immunofluorescence did not show linear deposition of IgG along the glomerular basement membrane.
Because of worsening respiratory failure, he was artificially ventilated. Renal function continued to deteriorate. Haemodialysis, immunosuppressive therapy consisting of cyclophosphamide 150mg/day and methylprednisolone 1 g/day for 3 days followed by prednisolone 60mg/day and plasma exchange were commenced.
After intensive therapy lasting 2 weeks and further blood transfusion of 8 units, his pulmonary and renal function improved. However the white cell count dropped to 2.2 x 109/l and cyclophosphamide was stopped. X-ray showed partial clearing of the shadows and he was weaned off the ventilator. Lung function testing 7 days later showed, as percentage predicted: forced expiratory volume in one second 53%, forced vital capacity 49%, diffusing capacity (DLCO) 119%.
Cyclophosphamide was recommenced after 12 days. He was maintained on 30 mg prednisolone daily; renal function was stable (serum creatinine 338 imol/l) without dialysis.
Six weeks after admission, he suddenly became dyspnoeic and coughed up large amounts of fresh blood. The haemoglobin level fell from 9 to 7.8 g/dl and repeat lung function tests showed a rise in his DLCO to 135% of predicted suggesting relapse of the disease.9 His chest X-ray deteriorated rapidly to virtual complete opacification.
Pulse therapy with methylprednisolone and cyclophosphamide were started, covered by erythromycin, cefuroxime and gentamicin. Despite artificial ventilation, gas exchange could not be maintained and the patient died 3 days later.
Permission was granted for a limited postmortem examination. This showed alveolar haemorrhage, consolidation, abscess formation in both lungs, and the presence of CMV inclusion bodies ( Figure 2b ) in both lungs. Sections of the kidneys showed 65% glomeruli with cellular crescents, with no immunoglobulin deposition, or vasculitis. CMV inclusion bodies were also found in the kidney, liver and pancreas.
Discussion
In the absence of anti-GBM antibody in the kidney Although sepsis is the main cause of death in idiopathic PHG,4 it was probably pulmonary haemorrhage rather than CMV infection that was the direct cause of his rapid demise. Wilson & Smith reported a case of PHG associated with influenza A2 infection5 and proposed that viral infection may induce antibodies reactive with the basement membrane which further perpetuated the disease. Relapse of anti-GBM disease6 and Wegener's granulomatosis7 has been associated with microbial infection, and the site of infection appears to determine the site of relapse.7 Thus, CMV infection in our patient may have a similar role in precipitating the fatal rebleed. His immunosuppressed state may have encouraged reactivation of latent virus but acquisition of infection through blood transfusion is an alternative explanation.8
The latter has been shown to occur in infants10 but can be largely eliminated by using blood from seronegative donors.11 Routine 
